Alkem Laboratories Approves Financial Results and Recommends Final Dividend
Alkem Laboratories Limited announced the approval of its Standalone and Consolidated Audited Financial Results for the quarter and financial year ended March 31, 2026. During the board meeting, the company also recommended a final dividend and approved the re-appointment of an executive director.The company provided comprehensive financial statements, including consolidated and standalone financial results, and detailed cash flow statements, reflecting its performance for the period ending March 31, 2026.
Financial Highlights (Year Ended March 31, 2026)
The audited financial results show significant figures for the year ended March 31, 2026.Consolidated Financial Results Summary (in Million)
| Metric | Year Ended 31 March 2026 (Audited) | Year Ended 31 March 2025 (Audited) |
|---|---|---|
| Total Income | 152,956.2 | 134,582.6 |
| Total Expenses | 122,499.0 | 109,312.3 |
| Profit for the Period (before OCI) | 23,511.6 | 22,153.8 |
| Total Comprehensive Income attributable to Owners of the Company | 24,841.8 | 21,862.3 |
Standalone Financial Results Summary (in Million)
| Metric | Year Ended 31 March 2026 (Audited) | Year Ended 31 March 2025 (Audited) |
|---|---|---|
| Total Income | 102,190.8 | 93,205.0 |
| Total Expenses | 75,533.7 | 70,169.6 |
| Profit for the Period (before OCI) | 22,820.9 | 22,808.9 |
Balance Sheet and Cash Position
As of March 31, 2026, the company reported substantial figures for its balance sheet.| Particulars | As at 31 March 2026 (Audited) | As at 31 March 2025 (Audited) |
|---|---|---|
| Total Assets | ||
| Total Non-current assets | 86,624.5 | 67,452.8 |
| Total Current assets | 122,105.2 | 108,111.9 |
| TOTAL ASSETS | 208,729.7 | 176,911.0 |
| Equity and Liabilities | ||
| Total Equity (Owners of the Company) | 138,201.0 | 119,848.7 |
| Total Non-current liabilities | 17,413.4 | 12,905.1 |
| Total Current liabilities | 47,827.0 | 39,606.7 |
| Total Liabilities | 208,729.7 | 176,911.0 |
The Statement of Consolidated Cash Flow for the year ended March 31, 2026, showed a Net cash generated from operating activities of 19,630.3 million.
Dividend and Governance Updates
The Board of Directors also took key decisions regarding dividends and corporate structure:- Dividend Recommendation: The Board recommended a final dividend of Rs. 10 (Rupees Ten only) per equity share (face value of Rs. 2 each) for the financial year ended March 31, 2026. This dividend is subject to shareholder approval at the ensuing Annual General Meeting.
- Director Re-appointment: The company approved the re-appointment of Mrs. Madhurima Singh as an Executive Director for five consecutive years, effective from December 20, 2026, up to December 19, 2031.
The Company fixed the 52nd Annual General Meeting (AGM) date for August 27, 2026. The cut-off date for the AGM has been set as August 20, 2026, and the record date for the payment of the final dividend is August 7, 2026.
***
Note: The full audited financial results and statements are available with the company.
ALKEM Stock Price Movement
On Wednesday, Alkem Laboratories Limited shares edged higher, closing at ₹5451.5, representing a daily gain of 1.77%. The equity traded volume of 186,374 shares, maintaining upward momentum through the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: